The University of Chicago Header Logo

Connection

Russell Z. Szmulewitz to Aminopyridines

Back to Details
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Aminopyridines.
Russell Z. Szmulewitz
Connection Strength
0.050
Aminopyridines
  1. A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1531-1539.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.